Results 101 to 110 of about 62,620 (348)

Vedolizumab for extraintestinal manifestations in pediatric inflammatory bowel disease: Results from the VedoKids study

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Extraintestinal manifestations (EIMs) manifest in 6%‐47% of patients with inflammatory bowel disease (IBD). Here, we characterize the course of EIMs in pediatric patients receiving vedolizumab included in the VedoKids cohort study. This was a subgroup analysis of the pediatric VedoKids cohort, a multicenter, prospective study of children (aged
Giulia D'Arcangelo, Dan Turner, Oren Ledder, Esther Orlanski‐Meyer, Efrat Broide, Maya Granot, Manar Matar, Seamus Hussey, Anat Yerushalmy‐Feler, Christoph Norden, Erasmo Miele, Marina Aloi   +11 more
wiley   +1 more source

Medical Management of Chronic Cholestatic Liver Diseases

Canadian Journal of Gastroenterology, 2000
The purpose of the present review is to discuss the diagnosis and management of cholestatic liver diseases. Differential diagnoses to consider are described, including causes of extrahepatic biliary obstruction such as gallstones, strictures ...
Andrea A Gossard, Keith D Lindor
doaj   +1 more source

Intrahepatic cholangiocarcinoma: review and update [PDF]

, 2018
Cholangiocarcinoma (CCA) is a heterogeneous group of malignancies that could develop at any level from the biliary tree. CCA is currently classified into intrahepatic (iCCA), perihilar and distal on the basis of its anatomical location.
Alvaro, Domenico, Bragazzi, Maria Consiglia, Cardinale, Vincenzo, Carpino, Guido, Di Matteo, Sabina, Gaudio, Eugenio, Nevi, Lorenzo, Overi, Diletta   +7 more
core   +1 more source

Hepatopulmonary syndrome in children and adolescents with portal hypertension in Brazil: A multicenter study

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives To describe the clinical and laboratory characteristics and outcomes of pediatric hepatopulmonary syndrome (HPS) secondary to portal hypertension (PH) in Brazil. Methods Fifty‐four pediatric patients diagnosed with PH and HPS according to the European Respiratory Society criteria were included in this multicenter retrospective study.
Leticia Drumond Alberto, Eleonora Druve Tavares Fagundes, Adriana Teixeira Rodrigues, Thaís Costa Nascentes Queiroz, Gustavo Valverde de Castro, Carlos Oscar Kieling, Sandra Maria Gonçalves Vieira, Natália Lamounier dos Martires Guerra, Natascha Silva Sandy, Gilda Porta, Irene Kazue Miura, Maria Ângela Bellomo Brandão, Gabriel Hessel, Adriana Maria Alves de Tommaso, Alexandre Rodrigues Ferreira   +14 more
wiley   +1 more source

Endothelin Signaling Mediates Biliary-Endothelial Crosstalk in Primary Sclerosing Cholangitis [PDF]

, 2023
Chunyue Yin
openalex   +1 more source

Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis

Hepatology, 2020
Many children with primary sclerosing cholangitis (PSC) receive oral vancomycin therapy (OVT) or ursodeoxycholic acid (UDCA). There is a paucity of data on whether these medications improve outcomes.
M. Deneau, C. Mack, D. Mogul, E. Perito, P. Valentino, A. Amir, Matthew DiGuglielmo, L. Draijer, W. El-Matary, K. Furuya, N. Gupta, Jessica T. Hochberg, S. Horslen, M. K. Jensen, M. Jonas, N. Kerkar, B. Koot, Trevor J. Laborda, Christine K. Lee, K. Loomes, Mercedes Martinez, A. Miethke, T. Miloh, S. Mohammad, N. Ovchinsky, Girish S Rao, A. Ricciuto, P. Sathya, K. Schwarz, U. Shah, Ruchi Singh, Bernadette E Vitola, A. Zizzo, S. Guthery   +33 more
semanticscholar   +1 more source

A case of autoimmune hepatitis in a patient with inflammatory bowel disease and significant lymphadenopathy in the porta hepatis

JPGN Reports, EarlyView.
Abstract The diagnosis of autoimmune hepatitis (AIH) is supported by the presence of elevated transaminases, hypergammaglobulinemia, liver biopsy consistent with AIH, and the presence of AIH autoantibodies. In this case presentation, we highlight the challenges associated with diagnosing AIH in a patient with inflammatory bowel disease (IBD) who ...
Benjamin J. Malamet, Shannon Joerger, Karen Caudill, Mai He, Juan Reyes Genere, Janis Stoll   +5 more
wiley   +1 more source

Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis [PDF]

, 2002
This report investigates the influence of liver transplantation and concomitant immunosuppression on the course of progression of inflammatory bowel disease (IBD) and discusses statistical methodology appropriate for such settings.
A. Jake Demetris, Abu-Elmagd, Befeler, Bleday, Brentnall, Chapman, Cottone, D'Haens, Fellermann, Gavaler, Greenstein, Hanauer, Higashi, Ierardi, Igor Dvorchik, John J. Fung, Kareem M. Abu-Elmagd, Katzka, Knechtle, Lichtiger, Loftus, Lowry, Michael Subotin, Miki, Narumi, Papatheodoridis, Papatheodoridis, Present, Rennick, Sahai, Samuel Wieand, Shaked, Stephens, Thomas E. Starzl   +33 more
core   +1 more source

DOP04 Single cell RNA sequencing identifies distinct intestinal inflammation patterns between primary sclerosing cholangitis-associated colitis and Ulcerative Colitis [PDF]

, 2021
Werna Uniken Venema, Amber Bangma, Monique G.P. van der Wijst, Gürsah Kats‐Ugurlu, Johannes R. Björk, Arnau Vich Vila, Rinse K. Weersma, Eleonora A. Festen   +7 more
openalex   +1 more source

Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies

World Journal of Gastroenterology, 2019
Primary sclerosing cholangitis (PSC) is a rare cholestatic liver disease characterized by progressive fibroinflammatory destruction of the intra- and/or extrahepatic biliary ducts. While its features and disease course can be variable, most patients with
Brian M. Fung, K. Lindor, J. Tabibian
semanticscholar   +1 more source